Filing Details

Accession Number:
0001127602-22-021400
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-19 18:16:30
Reporting Period:
2022-08-18
Accepted Time:
2022-08-19 18:16:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
318154 Amgen Inc AMGN Biological Products, (No Disgnostic Substances) (2836) 953540776
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1194256 Robert Eckert One Amgen Center Drive
Thousand Oaks CA 91320-1799
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-08-18 6,600 $249.00 21,184 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The price reported is an average price. The prices ranged from $248.73 to $249.19 per share. Full information regarding the number of shares purchased at each separate price within such range is available upon request by the SEC staff, the issuer or a security holder of the issuer.
  2. These shares include 2,008 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.